{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:30:42Z","timestamp":1793813442944,"version":"4.6.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["BJ23036"],"award-info":[{"award-number":["BJ23036"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ibneur.2026.09.001","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:55:56Z","timestamp":1788951356000},"page":"809-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lower lipoprotein(a) levels in patients with acute lacunar infarction"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-2941","authenticated-orcid":false,"given":"Xiangliang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1890-8909","authenticated-orcid":false,"given":"Fuping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ibneur.2026.09.001_bib1","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.STR.0000090351.41662.91","article-title":"Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging: risk factors, recurrence, and outcome in 175 consecutive cases","volume":"34","author":"Arauz","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.ibneur.2026.09.001_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2741\/1194","article-title":"Apoprotein (A) antagonises THE GPIIB\/IIIA receptor on collagen and adp-stimulated human platelets","volume":"9","author":"Barre","year":"2004","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.ibneur.2026.09.001_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.thromres.2006.04.013","article-title":"Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb\/IIIa) receptor","volume":"119","author":"Barre","year":"2007","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.ibneur.2026.09.001_bib4","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.ibneur.2026.09.001_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCULATIONAHA.124.069556","article-title":"Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis","volume":"151","author":"Bhatia","year":"2025","journal-title":"Circulation"},{"issue":"52","key":"10.1016\/j.ibneur.2026.09.001_bib6","doi-asserted-by":"crossref","first-page":"31151","DOI":"10.1074\/jbc.270.52.31151","article-title":"Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein","volume":"270","author":"Blencowe","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.ibneur.2026.09.001_bib7","doi-asserted-by":"crossref","first-page":"18149","DOI":"10.1016\/S0021-9258(18)55248-0","article-title":"Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase","volume":"266","author":"Borth","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ibneur.2026.09.001_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jcp.55.4.280","article-title":"Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk","volume":"55","author":"Byrne","year":"2002","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.ibneur.2026.09.001_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.17.1.2","article-title":"Lacunar infarction and small vessel disease: pathology and pathophysiology","volume":"17","author":"Caplan","year":"2015","journal-title":"J. Stroke"},{"issue":"4","key":"10.1016\/j.ibneur.2026.09.001_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1212\/WNL.58.4.653","article-title":"Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease","volume":"58","author":"Cerrato","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ibneur.2026.09.001_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12883-021-02043-9","article-title":"Association of neuroimaging markers of cerebral small vessel disease with short-term outcomes in patients with minor cerebrovascular events","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Neurol."},{"issue":"26","key":"10.1016\/j.ibneur.2026.09.001_bib12","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ibneur.2026.09.001_bib13","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/STROKEAHA.122.042323","article-title":"Lipoprotein(a) Is Associated With the Progression and Vulnerability of New-Onset Carotid Atherosclerotic Plaque","volume":"54","author":"Duan","year":"2023","journal-title":"Stroke"},{"issue":"19","key":"10.1016\/j.ibneur.2026.09.001_bib14","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"European Heart Rhythm","year":"2010","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ibneur.2026.09.001_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7150\/ijms.5272","article-title":"Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease","volume":"10","author":"Feng","year":"2013","journal-title":"Int. J. Med. Sci."},{"issue":"48","key":"10.1016\/j.ibneur.2026.09.001_bib16","doi-asserted-by":"crossref","first-page":"15777","DOI":"10.1021\/bi00048a023","article-title":"Analysis of the proteolytic activity of a recombinant form of apolipoprotein(a)","volume":"34","author":"Gabel","year":"1995","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.ibneur.2026.09.001_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/01616412.1992.11740076","article-title":"Plasma lipoproteins in cortical versus lacunar infarction with or without cardiac arrhythmia, and in transient ischaemic attacks: a case control study","volume":"14","author":"Giroud","year":"1992","journal-title":"Neurol. Res."},{"issue":"10","key":"10.1016\/j.ibneur.2026.09.001_bib18","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1161\/01.STR.30.10.2013","article-title":"Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden","volume":"30","author":"Glader","year":"1999","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ibneur.2026.09.001_bib19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/01.ATV.16.5.648","article-title":"Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes","volume":"16","author":"Gries","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.ibneur.2026.09.001_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00041433-199906000-00005","article-title":"Lipoprotein(a): intrigues and insights","volume":"10","author":"Hobbs","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"issue":"4","key":"10.1016\/j.ibneur.2026.09.001_bib21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.STR.0000157949.34986.30","article-title":"Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts","volume":"36","author":"Jackson","year":"2005","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ibneur.2026.09.001_bib22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/STROKEAHA.109.558809","article-title":"Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy?","volume":"41","author":"Jackson","year":"2010","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.ibneur.2026.09.001_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0021-9150(98)00085-9","article-title":"Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study","volume":"139","author":"Kargman","year":"1998","journal-title":"Atherosclerosis"},{"issue":"26","key":"10.1016\/j.ibneur.2026.09.001_bib24","doi-asserted-by":"crossref","first-page":"19819","DOI":"10.1016\/S0021-9258(19)36587-1","article-title":"Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100","volume":"268","author":"Koschinsky","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ibneur.2026.09.001_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.atherosclerosis.2014.01.054","article-title":"Lipoprotein(a) in various conditions: to keep a sense of proportions","volume":"234","author":"Kronenberg","year":"2014","journal-title":"Atherosclerosis"},{"issue":"39","key":"10.1016\/j.ibneur.2026.09.001_bib26","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ibneur.2026.09.001_bib27","doi-asserted-by":"crossref","first-page":"15660","DOI":"10.1038\/s41598-021-95141-0","article-title":"Lipoprotein (a) level as a risk factor for stroke and its subtype: A systematic review and meta-analysis","volume":"11","author":"Kumar","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ibneur.2026.09.001_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2019.03.524","article-title":"Elevated Lipoprotein(a) and Risk of Ischemic Stroke","volume":"74","author":"Langsted","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"22","key":"10.1016\/j.ibneur.2026.09.001_bib29","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/CIRCULATIONAHA.120.045826","article-title":"Lipoprotein(a) in Alzheimer, atherosclerotic, cerebrovascular, thrombotic, and valvular disease: mendelian randomization investigation","volume":"141","author":"Larsson","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ibneur.2026.09.001_bib30","first-page":"855","article-title":"Localization of tissue plasminogen activator in the endothelium of a limited number of vessels","volume":"144","author":"Levin","year":"1994","journal-title":"Am. J. Pathol."},{"issue":"23","key":"10.1016\/j.ibneur.2026.09.001_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24234414","article-title":"Forty years since the structural elucidation of platelet-activating factor (PAF): historical, current, and future research perspectives","volume":"24","author":"Lordan","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ibneur.2026.09.001_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/01.ATV.10.2.240","article-title":"Lipoprotein(a), fibrin binding, and plasminogen activation","volume":"10","author":"Loscalzo","year":"1990","journal-title":"Arteriosclerosis"},{"issue":"1","key":"10.1016\/j.ibneur.2026.09.001_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/17474930221144911","article-title":"Cerebral small vessel disease: recent advances and future directions","volume":"18","author":"Markus","year":"2023","journal-title":"Int. J. Stroke"},{"issue":"7","key":"10.1016\/j.ibneur.2026.09.001_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jcp.53.7.487","article-title":"Lipoprotein (a) and stroke","volume":"53","author":"Milionis","year":"2000","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.ibneur.2026.09.001_bib35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2015.08.021","article-title":"Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis","volume":"242","author":"Nave","year":"2015","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.ibneur.2026.09.001_bib36","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1161\/STROKEAHA.119.026872","article-title":"Causal Effect of Lp(a) [Lipoprotein(a)] Level on ischemic stroke and Alzheimer disease: a mendelian randomization study","volume":"50","author":"Pan","year":"2019","journal-title":"Stroke"},{"issue":"2-3","key":"10.1016\/j.ibneur.2026.09.001_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000097640","article-title":"Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke","volume":"23","author":"Petersen","year":"2007","journal-title":"Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.ibneur.2026.09.001_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0021-9150(00)00719-X","article-title":"Lipoprotein (a) and development of intermittent claudication and major cardiovascular events in men and women: the Edinburgh Artery Study","volume":"157","author":"Price","year":"2001","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.ibneur.2026.09.001_bib39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamaneurol.2018.1073","article-title":"Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review","volume":"75","author":"Regenhardt","year":"2018","journal-title":"JAMA Neurol."},{"issue":"16","key":"10.1016\/j.ibneur.2026.09.001_bib40","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.1995.03520400039041","article-title":"Plasma concentration of lipoprotein(a) and the risk of future stroke","volume":"273","author":"Ridker","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ibneur.2026.09.001_bib41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.thromres.2020.12.014","article-title":"How significant is the antifibrinolytic effect of lipoprotein(a) for blood clot lysis?","volume":"198","author":"Rijken","year":"2021","journal-title":"Thromb. Res."},{"issue":"20","key":"10.1016\/j.ibneur.2026.09.001_bib42","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/WNL.0000000000000980","article-title":"Plasma lipids and cerebral small vessel disease","volume":"83","author":"Schilling","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ibneur.2026.09.001_bib43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5114\/fn.2021.112007","article-title":"Risk factors for ischemic stroke: differences between cerebral small vessel and large artery atherosclerosis aetiologies","volume":"59","author":"Shi","year":"2021","journal-title":"Folia Neuropathol."},{"issue":"4","key":"10.1016\/j.ibneur.2026.09.001_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/svn-2020-000813","article-title":"Metabolic syndrome, intracranial arterial stenosis and cerebral small vessel disease in community-dwelling populations","volume":"6","author":"Shu","year":"2021","journal-title":"Stroke Vasc. Neurol."},{"issue":"17","key":"10.1016\/j.ibneur.2026.09.001_bib45","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1016\/S0021-9258(18)99133-7","article-title":"Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor","volume":"266","author":"Smiley","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ibneur.2026.09.001_bib46","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/STROKEAHA.106.480657","article-title":"Lipoprotein (a) and stroke: a meta-analysis of observational studies","volume":"38","author":"Smolders","year":"2007","journal-title":"Stroke"},{"issue":"17","key":"10.1016\/j.ibneur.2026.09.001_bib47","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1016\/S0021-9258(18)99132-5","article-title":"Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates","volume":"266","author":"Stremler","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ibneur.2026.09.001_bib48","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.STR.0000078370.12085.02","article-title":"Pentanucleotide TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: a multicenter case-control study in China","volume":"34","author":"Sun","year":"2003","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.ibneur.2026.09.001_bib49","article-title":"Associations of plasma LP(a), Hcy and D-D levels with the subtype of ischemic cerebrovascular disease","volume":"98","author":"Tang","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"6522","key":"10.1016\/j.ibneur.2026.09.001_bib50","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/374549a0","article-title":"Anti-inflammatory properties of a platelet-activating factor acetylhydrolase","volume":"374","author":"Tjoelker","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ibneur.2026.09.001_bib51","first-page":"13","article-title":"Oxidized phospholipids and lipoprotein-associated phospholipase A(2) as important determinants of Lp(a) functionality and pathophysiological role","volume":"31","author":"Tselepis","year":"2018","journal-title":"J. Biomed. Res."},{"issue":"1","key":"10.1016\/j.ibneur.2026.09.001_bib52","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cardiores.2004.03.005","article-title":"Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase","volume":"63","author":"Tsironis","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ibneur.2026.09.001_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2021.06.004","article-title":"Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK (PARISK) study","volume":"329","author":"van Dam-Nolen","year":"2021","journal-title":"Atherosclerosis"},{"issue":"24","key":"10.1016\/j.ibneur.2026.09.001_bib54","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1001\/jama.2017.7596","article-title":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013","volume":"317","author":"Wang","year":"2017","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ibneur.2026.09.001_bib55","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","article-title":"Status of Hypertension in China: results from the China Hypertension Survey, 2012-2015","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ibneur.2026.09.001_bib56","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/jnnp.2004.039982","article-title":"What causes lacunar stroke?","volume":"76","author":"Wardlaw","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.ibneur.2026.09.001_bib57","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/STROKEAHA.113.001500","article-title":"Smoking and hemorrhagic stroke mortality in a prospective cohort study of older Chinese","volume":"44","author":"Xu","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ibneur.2026.09.001_bib58","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ibneur.2026.09.001_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yjmcc.2017.08.016","article-title":"The oxidized phospholipid POVPC impairs endothelial function and vasodilation via uncoupling endothelial nitric oxide synthase","volume":"112","author":"Yan","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.ibneur.2026.09.001_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1751-2980.2008.00332.x","article-title":"Guidelines for the diagnosis and treatment of alcoholic liver disease","volume":"9","author":"Zeng","year":"2008","journal-title":"J. Dig. Dis."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:44:04Z","timestamp":1793810644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242126001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":60,"alternative-id":["S2667242126001478"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.09.001","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower lipoprotein(a) levels in patients with acute lacunar infarction","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}